Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Emraclidine is a positive allosteric modulator (PAM) of M4 muscarinic acetylcholine receptors (mAChRs).1 It is selective for M4 mAChRs over a panel of 59 receptors, ion channels, transporters, and enzymes at 10 µM. Emraclidine selectively potentiates ACh-induced activation of the M4 mAChR over M1-M3 and M5 mAChRs in cells expressing the human receptors (EC50s = 12.3, 4,798, >10,000, >10,000, and >10,000 nM, respectively). In vivo, emraclidine (3.2 mg/kg) inhibits amphetamine-induced locomotor activity in mice and prepulse inhibition deficits in rats.
WARNING This product is not for human or veterinary use.
1. Design and synthesis of clinical candidate PF-